Final Programme - iuphar

FC13 Maximising benefits and minimizing harms from
drugs
Thu 110 Lacritin, a novel secretagogue, increases tear flow in rabbits
Sandeep Samudre, (USA), J Sheppard, F Lattanzio, G Laurie, R McKown, P Williams
Thu 111 Crono-pharmacokinetic of irinotecan after hepatic intra arterial perfusion in patients with metastatic
colon carcinoma
Francesco Scaglione, (Italy), S Bareggi, A Nasisi, G Bondiolotti, M Pirovano
Thu 112 Blunted reward system activation to erotic stimuli under paroxetine as compared to bupropion or
placebo in healthy subjects
Angela Seeringer, (Germany), B Abler, A Hartmann, G Groen, M Walter, J Kirchheiner
Thu 113 Transient neurological disturbance in a patient with lamotrigine overdose
Anshuman Sengupta, (UK), O Martin, G Lane, P Patel, S Abbasi
Thu 114 Plasma serotonin levels and influence of granisetron on pharmacokinetics and pharmacodynamics of
omeprazole in healthy subjects and patients with peptic ulcer disease
Svetlana Serebrova, (Russian Federation), A Starodubtzev, S Kondratenko, G Belyakova, N Berdnikova
Thu 115 Amphotericin B molecular organization and the particle size as essential factors to reduce its toxicity
by hemolysis
Dollores R Serrano Lopez, (Spain), HKR Saldaña, JJT Durán, MP Ballesteros, ST Durán
Thu 116 Chemical forms of mercurials differentiate the potential of mercury for toxicity from that for medicinal
remedy
Jing Zhen Shi, (PR China), F Kang, Q Wu, YF Lu, J Liu, YJ Kang
Thu 117 Effect of a novel fungal triprenyl phenol metabolite (Cpd-7) on acetic acid-induced embolic cerebral
infarction model in mice
Keita Shibata, (Japan), T Hashimoto, K Nobe, K Hasumi, K Honda
Thu 118 Evaluation of clinical relevance of drug interactions based on metabolism: comparison of two CDK
inhibitors
Michal Siller, (Czech Republic), P Anzenbacher, E Anzenbacherova, K Dolezal, M Strnad
Thu 119 Antihypertensive treatment and blood pressure control in primary health care
D Silva, Isabel Vitórial Figueiredo, (Portugal), A Figueiras, MT Herdeiro, M Caramona, J Polónia
Thu 120 Drug use pattern in hospital outpatients and private practice in Sylhet city of Bangladesh
Sharadindu Kanti Sinha, (Bangladesh), WR Choudhury, MR Choudhury
Thu 121 SLCO1B1 and CYP2C9 genetic variants could be associated with fluvastatin induced side effects in
solid organ allotransplant recipients: case series
NM Skvrce, L Zibar, Nada Božina, (Croatia), VM Sarinic, S Tomic
Thu 122 Effects of fullerenol on rat uterus contraction and antioxidative enzymes activity
Marija Slavic, (Republic of Serbia), Z Orescanin-Dusic, R Radojicic, S Milovanovic, A Djordjevic,
M Spasic, D Blagojevic
Thu 123 The HLA class I B*1801 allele influences hepatocellular expression of amoxicillin-clavulanate liver
damage and outcome in Spanish patients
Camilla Stephens, (Spain), MA Lopez-Nevot, RJ Andrade, F Ruiz-Cabello, MC Fernandez, C Guarner,
G Soriano, M Romero-Gomez, JM Navarro, JL Solís-Herruzo, J Costa, MI Lucena
Thu 124 Antimicrobial consumption and polypharmacy in patients on immunosuppressive therapy
Jan Strojil, (Czech Republic), P Langerová, K Urbánek
288 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area